famotidine
Generic: famotidine
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
famotidine
Generic Name
famotidine
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
famotidine 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-739
Product ID
63323-739_241710d5-bcef-4852-a09c-0e681250e6aa
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075813
Listing Expiration
2026-12-31
Marketing Start
2001-03-15
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323739
Hyphenated Format
63323-739
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
famotidine (source: ndc)
Generic Name
famotidine (source: ndc)
Application Number
ANDA075813 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 25 VIAL, SINGLE-USE in 1 TRAY (63323-739-16) / 2 mL in 1 VIAL, SINGLE-USE (63323-739-41)
Packages (1)
Ingredients (1)
Linked Drug Pages (2)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "241710d5-bcef-4852-a09c-0e681250e6aa", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0363323739416"], "unii": ["5QZO15J2Z8"], "rxcui": ["1743833"], "spl_set_id": ["ce533636-cc9b-45d0-87a6-5390377ff28a"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-USE in 1 TRAY (63323-739-16) / 2 mL in 1 VIAL, SINGLE-USE (63323-739-41)", "package_ndc": "63323-739-16", "marketing_start_date": "20010315"}], "brand_name": "Famotidine", "product_id": "63323-739_241710d5-bcef-4852-a09c-0e681250e6aa", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "63323-739", "generic_name": "Famotidine", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "10 mg/mL"}], "application_number": "ANDA075813", "marketing_category": "ANDA", "marketing_start_date": "20010315", "listing_expiration_date": "20261231"}